Showing results (71-80 of 6,941) with videos related to
Sort By:
Pageof 695
Gynecologic Oncology|May 1, 1996
Mitotic count, nuclear atypia, and immunohistochemical determination of Ki-67, c-myc, p21-ras, c-erbB2, and p53 expression in granulosa cell tumors of the ovary: mitotic count and Ki-67 are indicators of poor prognosisL A King, T Okagaki, D G Gallup, et al.Gynecologic Oncology|November 1, 1994
Salvage surgery for chemorefractory ovarian germ cell tumorsA Munkarah, D M Gershenson, C Levenback, et al.The Journal of Family Practice|August 1, 1996
Atypical glandular cells of undetermined significance and adenocarcinoma in situ: summoning colposcopic expertise?D G Ferris, B A Krumholz, D M Jester, et al.JIMD Reports|April 17, 2013
Substrate Reduction Therapy in Four Patients with Milder CLN1 Mutations and Juvenile-Onset Batten Disease Using Cysteamine BitartrateM Gavin, G Y Wen, J Messing, et al.TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|November 20, 2013
High frequency callus formation from maize protoplastsS R Ludwig, D A Somers, W L Petersen, et al.Structure (London, England : 1993)|March 13, 2009
Structure and biological function of the RNA pyrophosphohydrolase BdRppH from Bdellovibrio bacteriovorusSimon A J Messing, Sandra B Gabelli, Quansheng Liu, et al.Nucleic Acids Research|August 14, 2012
The processing of repetitive extragenic palindromes: the structure of a repetitive extragenic palindrome bound to its associated nucleaseSimon A J Messing, Bao Ton-Hoang, Alison B Hickman, et al.Gynecologic Oncology|August 7, 2004
Phase II study of sequential doublets: topotecan and carboplatin, followed by paclitaxel and carboplatin, in patients with newly diagnosed advanced ovarian cancerAlan N Gordon, Lina Asmar, Mark J Messing, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
Phase II evaluation of nanoparticle albumin-bound paclitaxel in platinum-sensitive patients with recurrent ovarian, peritoneal, or fallopian tube cancerMichael G Teneriello, Paul C Tseng, Mark Crozier, et al.Pageof 695